We are live on ! Find out more
Globeflex Capital

Globeflex Capital Portfolio holdings

AUM $783M Turnover 28.73%
1-Year Est. Return 81.58%
This Fund
S&P 500
This Quarter Est. Return
+34.81%
1 Year Est. Return
+81.58%
3 Year Est. Return
+185.88%
5 Year Est. Return
+280.02%
10 Year Est. Return
+1,365.88%
AUM
$783M
AUM Growth
+$122M
Cap. Flow
-$22.1M
Cap. Flow %
-2.82%
Top 10 Hldgs %
18.08%
Holding
456
New
69
Increased
67
Reduced
73
Closed
62
Avg Time Held
1.9 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.4 years

Top Buys

Rank Stock Value
1
CIEN icon
Ciena
CIEN
+$6.96M
2
MYRG icon
MYR Group
MYRG
+$4.57M
3
DRS icon
Leonardo DRS
DRS
+$4.16M
4
SMTC icon
Semtech
SMTC
+$3.99M
5
P icon
Everpure Inc
P
+$3.43M

Sector Composition

Rank Sector Weight
1 Technology 27.29%
2 Industrials 19.78%
3 Financials 17.73%
4 Healthcare 17.14%
5 Consumer Discretionary 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
IFS icon
1
Intercorp Financial Services
IFS
$5.2B
$23.3M 2.98%
408,951
-20,594
-5% -$1.02M
2025 Q1
5 quarters
BLBD icon
2
Blue Bird Corp
BLBD
$1.9B
$15.6M 2%
197,872
+69
+0% +$4.68K
2024 Q1
9 quarters
EXEL icon
3
Exelixis
EXEL
$16.9B
$13.9M 1.77%
254,993
-5,713
-2% -$278K
2021 Q1
21 quarters
CPA icon
4
Copa Holdings
CPA
$5.26B
$13.6M 1.74%
87,283
– –
2013 Q2
52 quarters
ATI icon
5
ATI
ATI
$22.5B
$13.2M 1.69%
67,186
-1,975
-3% -$335K
2025 Q1
5 quarters
MKSI icon
6
MKS Inc
MKSI
$13.7B
$13M 1.66%
29,241
-5,713
-16% -$1.79M
2024 Q2
8 quarters
MRX
7
Marex Group Limited Ordinary Shares
MRX
$4.63B
$12.9M 1.65%
212,125
– –
2025 Q3
3 quarters
ENS icon
8
EnerSys
ENS
$5.77B
$12.7M 1.62%
54,162
-2,548
-4% -$553K
2023 Q2
12 quarters
KLIC icon
9
Kulicke & Soffa
KLIC
$3.88B
$11.9M 1.52%
88,998
-9,030
-9% -$885K
2025 Q3
3 quarters
DAVE icon
10
Dave Inc
DAVE
$4.04B
$11.4M 1.46%
30,606
+3,985
+15% +$1.04M
2025 Q3
3 quarters
SNX icon
11
TD Synnex
SNX
$18.9B
$10.7M 1.37%
40,040
+4,816
+14% +$1.16M
2024 Q1
9 quarters
CRUS icon
12
Cirrus Logic
CRUS
$5.5B
$10.6M 1.35%
71,224
-653
-0.9% -$107K
2020 Q2
24 quarters
ESE icon
13
ESCO Technologies
ESE
$6.16B
$10.3M 1.32%
29,489
-2,792
-9% -$874K
2025 Q1
5 quarters
YPF icon
14
YPF Sociedad Anonima ADS
YPF
$18.4B
$10.1M 1.29%
221,544
– –
2021 Q4
18 quarters
HST icon
15
Host Hotels & Resorts
HST
$17.3B
$9.7M 1.24%
409,143
+893
+0.2% +$19.9K
2025 Q2
4 quarters
TBLA icon
16
Taboola.com
TBLA
$935M
$9.6M 1.22%
1,910,929
+3,914
+0.2% +$17.1K
2024 Q4
6 quarters
ANIP icon
17
ANI Pharmaceuticals
ANIP
$1.65B
$8.99M 1.15%
108,569
+24,424
+29% +$1.96M
2023 Q2
12 quarters
ECPG icon
18
Encore Capital Group
ECPG
$2.12B
$8.79M 1.12%
94,244
-1,828
-2% -$149K
2025 Q3
3 quarters
FIX icon
19
Comfort Systems
FIX
$43.4B
$8.5M 1.09%
4,291
-647
-13% -$1.17M
2024 Q4
6 quarters
NTB icon
20
Bank of N.T. Butterfield & Son
NTB
$2.22B
$8.23M 1.05%
138,249
+280
+0.2% +$15.8K
2018 Q1
33 quarters
RSI icon
21
Rush Street Interactive
RSI
$1.39B
$7.88M 1.01%
264,840
-27,894
-10% -$735K
2024 Q4
6 quarters
ACLS icon
22
Axcelis
ACLS
$3.09B
$7.42M 0.95%
39,162
-5,293
-12% -$785K
2017 Q3
35 quarters
FTDR icon
23
Frontdoor
FTDR
$6.04B
$7.11M 0.91%
91,610
+343
+0.4% +$21.9K
2023 Q2
12 quarters
TILE icon
24
Interface
TILE
$2.13B
$6.98M 0.89%
194,715
-6,271
-3% -$183K
2024 Q1
9 quarters
AIZ icon
25
Assurant
AIZ
$14.4B
$6.83M 0.87%
25,435
-83
-0.3% -$20.2K
2023 Q2
12 quarters

Similar funds

Globeflex Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Globeflex Capital held 456 positions worth $783M, up 18% from $661M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Globeflex Capital's Q2 2026 filing shows 69 new, 67 increased, 73 reduced and 62 closed positions. Its largest new stake was Ciena: 13,648 shares worth $6.7M. The largest sale was Catalyst Pharmaceutical, an estimated $11.2M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 23% a quarter earlier, followed by Industrials and Financials.

  • Globeflex Capital's largest Q2 2026 buy was Ciena: 13,648 shares worth $6.7M.
  • Globeflex Capital added most to MYR Group in Q2 2026, an estimated $4.57M increase.
  • Globeflex Capital's biggest Q2 2026 reduction was Rigel Pharmaceuticals, cutting an estimated $3.24M.
  • Globeflex Capital fully exited Catalyst Pharmaceutical in Q2 2026, selling an estimated $11.2M.
  • Globeflex Capital's ten largest holdings make up 18% of its $783M portfolio in Q2 2026.
  • Globeflex Capital opened 69 new positions and closed 62 in Q2 2026.
  • Globeflex Capital's portfolio value rose 18% quarter-over-quarter to $783M.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.